Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$0.07 CAD
Change Today -0.005 / -6.67%
Volume 760.2K
EKG On Other Exchanges
As of 3:48 PM 07/27/15 All times are local (Market data is delayed by at least 15 minutes).

cardiocomm solutions inc (EKG) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/2/15 - C$0.14
52 Week Low
10/15/14 - C$0.03
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

cardiocomm solutions inc (EKG) Related Businessweek News

No Related Businessweek News Found

cardiocomm solutions inc (EKG) Details

CardioComm Solutions, Inc. is engaged in the development of hardware and software for the cardiology field in the United States, Canada, and other countries. The company’s technology is used in various products for recording, viewing, analyzing, and storing electrocardiograms (ECGs) for the diagnosis and management of cardiac patients. Its software products include Global ECG Management System (GEMS), a software solution for cardiac event monitoring; GlobalCardio 3 Lead; GlobalCardio 12 Lead, a Web enabled portable ECG device that is electronic medical records (EMR) compatible; and ECG Viewer SDK. The company also offers software modules, such as GEMS Air, a live wireless ECG monitoring solution; AutoAttendant, which allows healthcare providers to focus on providing patient care; GEMS HL7 and EMR Interface that allows patient and follow-up information to be sent in an HL7 message format to other EMR systems that are HL7 compliant; GlobalCardio EMR integration that integrates with EMR and enables bidirectional movement of data; and GEMS Lite, an electronic ECG receiving system. In addition, it provides hardware products comprising HeartCheck, a handheld ECG monitors; HeartCheck PEN; QRS Diagnostic; Cardiac Science Atria ECG recorders; DR200/HE, a holter and event recorder; Burdick Atria 3100 ECG, an electrocardiogram system for private practices; Burdick Atria 6100 ECG, a portable ECG/EKG system for hospitals and cardiology clinics; GEMSTrak AF, a cardiac event recorder with atrial fibrillation auto-capture; and ECG electrodes. Further, the company offers ASP services, including C4 ECG management services. It serves hospitals, call centers, and physician’s offices through a combination of the company’s external distribution network and sales team. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in North York, Canada.

Founded in 1989

cardiocomm solutions inc (EKG) Top Compensated Officers

Chief Executive Officer, Corporate Secretary,...
Total Annual Compensation: C$250.0K
Chief Financial Officer
Total Annual Compensation: C$30.0K
Compensation as of Fiscal Year 2014.

cardiocomm solutions inc (EKG) Key Developments

CardioComm Solutions, Inc. Enters into Distributor Agreement with Innovative Medical Solutions

CardioComm Solutions Inc. announced it has entered into a distributor agreement with Innovative Medical Solutions (Innovative Medical) located in Perth, Western Australia for development of commercial distribution channels for the sale of the HeartCheckTM PEN and the HeartCheckTM ECG Monitor as well as CardioComm Solutions' ECG management software solutions known as GEMSTM WIN and SMART Monitoring through consumer sales channels, pharmaceutical companies, pharmacies, hospitals, clinics and health care providers within Australia. Completion of the agreement will allow CardioComm Solutions and Innovative Medical to benefit from software enhancements that will have to be undertaken in response to the deadline for WINDOWS operating system upgrades away from Server 2003. CardioComm Solutions has previously reported requirements for ECG service providers to replace their existing ECG management solutions to versions that are WIN 7 and Server 2008 compatible. CardioComm Solutions released its GEMSTM WIN software upgrade to the arrhythmia monitoring market in response to the 2014 discontinuation of XP support by Microsoft and the imminent discontinuation of Server 2003 in July 2015.

CardioComm Solutions Inc. Announces Global Agreement with IntriCon Corporation to Expand Gems(TM)

CardioComm Solutions Inc. announced that it has entered into an ECG device and software distribution and marketing agreement with Minnesota based IntriCon Corporation. CardioComm Solutions will benefit directly from devices sales as an authorized distributor of the Sirona devices with preferred distributor pricing which will translate into competitive pricing to the Company's Global ECG Management Solution for Windows customer base. Hardware sales will commence in Canada and the USA with the anticipation that the Sirona device will have the needed CE Mark provided for sales to be possible in Europe by the end of this year. Under the agreement, CardioComm Solutions has developed a custom interoptability between IntriCon's Sirona ECG device and the Company's proprietary wireless GEMS' WIN module and ("GEMS' AIR"). This integration will allow GEMS'WIN licensors to incorporate the Sirona device into their business operations for use alongside their existing ambulatory ECG/arrhythmia monitoring device inventory.

CardioComm Solutions to Launch the HeartCheck ECG PEN with Bluetooth for Wireless Android and Apple Smartphone Connectivity

CardioComm Solutions Inc. announced that it will introduce a Bluetooth HeartCheck" PEN for wireless connectivity to Android and Apple Smartphones by the first quarter of 2016. The company has completed the development and testing of a pre-production version of the Bluetooth HeartCheck" ECG PEN and a Smartphone application that will wirelessly connect the Bluetooth ECG PEN to the Company's SMART Monitoring ECG service. With the review of FDA and Health Canada requirements completed and confirming a Bluetooth enabled version of the HeartCheck" ECG PEN can be sold under the Company's current and existing medical device approvals, the release of the wireless version of the HeartCheck" ECG PEN can occur with material time and cost savings. The Bluetooth HeartCheck" ECG PEN model will retain the same form factor and use-advantages as the current ECG PEN version. It will allow ECGs to be viewed on the device while heart rhythm recordings are taken and for the storage and replaying of up to 20 ECGs. In addition to wireless communication, the Company will maintain the device's USB connectivity to a Windows-based PC which is critical where cellular coverage may be unreliable. The ability to connect to Smartphones will provide CardioComm Solutions access to an expansive mobile health consumer market not previously marketed to. Two advantages and major product differentiators of the Bluetooth HeartCheck" ECG PEN versus other Smartphone-connected ECG monitoring devices are: Use of the device is not dependent on a Smartphone: ECG recordings by other devices are not possible if they are not physically near the Smartphone, if the phone is out of power or if cellular reception is not available; and No physician prescription is required as a condition to be able to see an ECG report. By developing their own Smartphone Application and tying to the Company's proprietary SMART Monitoring ECG services solutions, CardioComm Solutions is now able to introduce other devices under the HeartCheck" brand for the medical, sport and consumer wireless wearable sensor markets. With the ability to leverage FDA, Health Canada, Chinese FDA, Australian TGA and European CE Mark software clearances/approvals, this would remove a need for such device manufacturers to develop their own costly software solutions and provide them a faster go to market opportunity. The current model of the device connects via a USB cable to the Windows-based GEMS" Home software for the transfer and management of recorded ECGs. GEMS" Home also allows for the ECG to be reviewed by the Company's SMART Monitoring ECG service for a fee. The response time for an ECG reading is within 30 minutes 24/7/365.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EKG:CN C$0.07 CAD -0.005

EKG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alere Inc $50.04 USD -0.89
LifeWatch AG SFr.16.05 CHF -0.35
View Industry Companies

Industry Analysis


Industry Average

Valuation EKG Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.1x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARDIOCOMM SOLUTIONS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at